Skip to main content
SpringerLink
Log in

Harnblasenkarzinom: Epidemiologie und Risikofaktoren

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 127 Accesses

Zusammenfassung

Das Harnblasenkarzinom zählt zu den häufigsten malignen Tumorerkrankungen weltweit. Verschiedene Untersuchungen belegen die Altersabhängigkeit und das tendenziell höhere Erkrankungsrisiko für das männliche Geschlecht. Noch immer sterben jährlich weltweit über 130.000 Menschen an diesem Tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Babaya K, Takahashi S, Momose H et al (1987) Effects of single chemotherapeutic agents in development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats. Urol Res 15:329–334

    Article  CAS  PubMed  Google Scholar 

  • Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA (1987) Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-result follow-up study. Am J Med 83:1–9

    Article  CAS  PubMed  Google Scholar 

  • Bedwani R, Renganathan E, El Kwhsky F et al (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77(7):1186–1189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boice JD Jr et al (1985) Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74(5):955–975

    PubMed  Google Scholar 

  • Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P et al (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86:289–294

    Article  CAS  PubMed  Google Scholar 

  • Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, Alavanja M, Craun G (1998) Drinking water source and chlorination byproducts. I. Risk of bladder cancer (see comments). Epidemiology 9(1):21–28

    Article  CAS  PubMed  Google Scholar 

  • Case RAM, Pearson JT (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II: further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents. Br J Ind Med 11:213

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen CH et al (2013) Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer 133(1):14–20

    Article  CAS  PubMed  Google Scholar 

  • Chow WH et al (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89(19):1453–1457

    Article  CAS  PubMed  Google Scholar 

  • Cole P (1971) Coffee-drinking and cancer of the lower urinary tract. Lancet i:1335

    Article  Google Scholar 

  • Coleman M, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, Knerer G, Pitard A, Quinn M, Scoggett A, De Stavoua B (1999) Cancer survival trends in England and Wales, 1971–1995: deprivation and NHS region. Stationary Office, London

    Google Scholar 

  • Collins J, Acquavella JF (1998) Review and meta-analysis of studies of acrylonitrile workers. Scand J Work Environ Health 24(Suppl 2):71–80

    CAS  PubMed  Google Scholar 

  • Deutz FJ, Rübben H, Küpper W, Hofstädter F (1988) Morphologie der Harnblase und des Darms nach Harnleiter-Sigmaimplantation unter Karzinogenexposition. 9. Symposium Experimentelle Urologie, Aachen, 16.–18.06.1988

    Google Scholar 

  • Donato F, Boffetta P, Fazioli R, Gelatti U, Porru S (1998) Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study. Eur J Epidemiol 14(3):259–267

    Article  CAS  PubMed  Google Scholar 

  • Fairchild WV, Spence CR, Solomon HD, Gangai MP (1979) The incidence of bladder cancer after cyclophosphamide therapy. J Urol 122:163

    Article  CAS  PubMed  Google Scholar 

  • Gonwa TA, Corbett WT, Schey HM, Buckalew VM (1980) Analgesic associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93:249

    Article  CAS  PubMed  Google Scholar 

  • Grotenhuis AJ, Ebben CW, Aben KK, Witjes JA, Vrieling A, Vermeulen SH, Kiemeney LA (2015) The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer. Urol Oncol 33(2):65.e9–65.17

    Article  Google Scholar 

  • Hueper WC, Wiley FH, Wolfe HD (1938) Experimental production or bladder tumours in dogs by administration of beta-naphthylamine. J Ind Hyg Toxicol 20(1):46

    CAS  Google Scholar 

  • Huff JE (1991) Carcinogenicity of ochratoxin A in experimental animals. IARC Sci Publ 115:229–224

    CAS  Google Scholar 

  • IARC Working Group on the Evaluation of Carcinogenic Risk to Humans (2012) Personal habits and indoor combustions. http://monographs.iarc.fr/ENG/Monographs/vol100E/index.php. Zugegriffen am 01.09.2019

  • Irving CC, Murphy WM, Damil DS (1984) Comparative carinogenicity of N-butyl-N-(3 carboxypropyl)-nitrosamin and N-butyl-N (4 hydroxybutyl) nitrosamine for the urinary bladder of (C5BL/6xDBA/2)F1 mice. JNCI 73(3):753–756

    CAS  PubMed  Google Scholar 

  • Ito N (1984) Histogenesis of urinary bladder tumors induced by nitrosamine in rats. J Cancer Res Clin Oncol 108:169–173

    Article  CAS  PubMed  Google Scholar 

  • Ito N (1988) Early changes caused by nitrosamine in the bladder epithelium of different animal species. Jpn J Cancer Res 79(4):413–417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johansson SL, Cohen SM (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13:291–298

    Article  CAS  PubMed  Google Scholar 

  • Kantor AF et al (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119(4):510–515

    Article  CAS  PubMed  Google Scholar 

  • Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B (1998) Design of an epidemiologie study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 106(Suppl 4):1047–1050

    Article  PubMed  PubMed Central  Google Scholar 

  • Kaufmann JM, Fam B, Jacobs SC, Gabrilondo F, Yalla S, Kane JP, Rossier AB (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118:967

    Article  Google Scholar 

  • Kunze E, Calude J, Frentzel-Beyme R (1986) Association of cancer of the lower urinary tract with consumption of alcoholic beverages – a case control study. Carcinogenesis 7:163

    Article  CAS  PubMed  Google Scholar 

  • Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S, for the Japan Public Health Center (JPHC) Study Group (2009) Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 100(2):294–91

    Google Scholar 

  • Lammers RJ, Witjes WP, Hendricksen K, Caris CT, Janzing-Pastors MH, Witjes JA (2011) Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol 60(4):713–720

    Article  PubMed  Google Scholar 

  • Larsson SC, Andersson SO, Johansson JE, Wolk A (2008a) Cultured milk, yoghurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men. Am J Clin Nutr 88(4):1083–1087

    Article  CAS  PubMed  Google Scholar 

  • Larsson SC, Andersson SO, Johansson JE, Wolk A (2008b) Friut and vegetable consumption and risk of bladder cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 17(9):2519–2522

    Article  Google Scholar 

  • Li HZ et al (2009) De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China. Urol Int 83(2):200–205

    Article  PubMed  Google Scholar 

  • Linn JFJ, Rübben H (1995) Die Wirkung von Keyhole-Limpet-Haemocyanin auf chemisch induzierte Blasentumore bei Ratten. Vergleich subkutaner vs. intraversikaler Applikation vs. Kontrollgruppe. 12. Symposium für experimentelle Urologie, Berlin, 18.03.1995

    Google Scholar 

  • Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H et al (2000) Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomark Prev 9:461–467

    CAS  Google Scholar 

  • McCredie M, Stewart JH, Ford JM, MacLennan RA (1983) Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 55:220–224

    Article  CAS  PubMed  Google Scholar 

  • Micheli A, Mariotto A, Giorgio Rossi A, Gatta G, Muti P (1998) Eurocare Working Group, The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 14:2271–2278

    Article  Google Scholar 

  • Mostafa MH, Helmi S, Badawi AF, Tricker AR, Spiegelhalder B, Preussmann R (1994) Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis 15:619–625

    Article  CAS  PubMed  Google Scholar 

  • Olson CA, De Vere White RW (1979) Cancer of the bladder. In: Javadpour N (Hrsg) Principles and management of urologic cancer. Williams & Wilkins, Baltimore, S 337

    Google Scholar 

  • Otto T, Rübben H (2004) Prävention des Harnblasenkarzinoms. Urologe A 43:562–564

    Article  CAS  PubMed  Google Scholar 

  • Parkin DM, Bray F, Ferley J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94(2):153–156

    Article  CAS  PubMed  Google Scholar 

  • Pashos CL, Botteman MF, Laskin BL, Redaelle A (2002) Bladder cancer: epidemiology, diagnosis and management. Cancer Pract 10(6):311–322

    Article  PubMed  Google Scholar 

  • Pearson RM, Soloway MS (1978) Does cyclophosphamide induce bladder cancer? Urology 4:437

    Article  Google Scholar 

  • Pedersen-Bjergaard J, Ersboll J, Hansen VL et al (1988) Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin lymphoma. N Engl J Med 318:1028–1032

    Article  CAS  PubMed  Google Scholar 

  • Petkova-Bocharova T, Castegnaro M (1991) Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumors in Bulgaria. IARC Sci Publ 115:135–137

    Google Scholar 

  • Petkovic S, Multavdzik M, Petronic V, Marcovic V (1971) Tumours of the renal pelvis and ureter: clinical and aetiologic studies. J Urol Nephrol (Paris) 77:429

    CAS  Google Scholar 

  • Probert JL, Persad RA, Greenwood RP, Gillatt DA, Smith PJ (1998) Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England. Br J Urol 82(5):660–666

    Article  CAS  PubMed  Google Scholar 

  • Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (Hrsg) (1999) SEER cancer statistics review, 1973–1996. NIH publication no 99–2789. National Cancer Institute, Bethesda

    Google Scholar 

  • Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al (2000) SEER cancer statistics review, 1973–1997. National Cancer Institute, Bethesda

    Google Scholar 

  • Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B (2000) Selected risk factors for transitional cell bladder cancer. Med Oncol 17:179–182

    Article  CAS  PubMed  Google Scholar 

  • Salem HK, Mahfouz S (2012) Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade. Urology 79(2):379–383

    Article  PubMed  Google Scholar 

  • Schulte PA, Ringen K, Hemstreet GP (1986) Risk factors for bladder cancer in cohort exposed to aromatic amines. Cancer 58:2156

    Article  CAS  PubMed  Google Scholar 

  • Shibata MA et al (1989) The role of BBN in F344 rats. J Toxicol Environ Health 26(3):255–265

    Article  CAS  PubMed  Google Scholar 

  • Smith AH, Goycolea M, Haque R, Biggs ML (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147(7):660–669

    Article  CAS  PubMed  Google Scholar 

  • Welk B et al (2013) Bladder cancer in individuals with spinal cord injuries. Spinal Cord 51(7):516–521

    Article  CAS  PubMed  Google Scholar 

  • Wigle DT (1998) Safe drinking water: a public health challenge. Chronic Dis Can 19(3):103–107

    CAS  PubMed  Google Scholar 

  • Zheng W, McLaughlin JK, Gao YT, Silverman DT, Gao RN, Blot WJ (1992) Bladder cancer and occupation in Shanghai, 1980–1984. Am J Ind Med 21:877–885

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Praxisklinik Essen, Essen, Deutschland

    Tobias Jäger

Authors
  1. Tobias Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tobias Jäger .

Editor information

Editors and Affiliations

  1. Helios Marien Klinikum Duisburg, Duisburg, Nordrhein-Westfalen, Germany

    Herbert Rübben

  2. Urologische Klinik/Poliklinik, Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Germany

    Oliver Hakenberg

  3. Klinik und Poliklinik für Urologie , Universitätsklinikum Jena, Jena, Thüringen, Germany

    Marc-Oliver Grimm

  4. Caritaskrankenhaus St. Josef, Regensburg, Germany

    Maximilian Burger

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Jäger, T. (2019). Harnblasenkarzinom: Epidemiologie und Risikofaktoren. In: Rübben, H., Hakenberg, O., Grimm, MO., Burger, M. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_38-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_38-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation